| 000 | 01181 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514204639.0 | ||
| 264 | 0 | _c20041209 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0889-8588 | ||
| 024 | 7 |
_a10.1016/j.hoc.2004.05.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPurow, Benjamin | |
| 245 | 0 | 0 |
_aAntiangiogenic therapy for primary and metastatic brain tumors. _h[electronic resource] |
| 260 |
_bHematology/oncology clinics of North America _cOct 2004 |
||
| 300 |
_a1161-81, x p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 |
_aBrain Neoplasms _xblood supply |
| 650 | 0 | 4 | _aCerebrovascular Circulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aFine, Howard A | |
| 773 | 0 |
_tHematology/oncology clinics of North America _gvol. 18 _gno. 5 _gp. 1161-81, x |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.hoc.2004.05.003 _zAvailable from publisher's website |
| 999 |
_c15165774 _d15165774 |
||